Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on March 21, 2008
This version was published on January 1, 2008
Neuro Oncol 2008 10(3):254-264; DOI:10.1215/15228517-2008-001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
10/3/254    most recent
15228517-2008-001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, R.
Right arrow Articles by Bergers, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Basic and Translational Investigations

Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM

Rose Du, Claudia Petritsch, Kan Lu, Patty Liu, Anna Haller, Ruth Ganss, Hanqiu Song, Scott Vandenberg and Gabriele Bergers

Departments of Neurological Surgery (R.D., C.P., K.L., P.L., A.H., H.S., S.V., G.B.) and Pathology (S.V.) and Brain Tumor Research Center and Comprehensive Cancer Center (C.P., G.B.), University of California San Francisco, San Francisco, CA, USA; Department of Neurological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (R.D.); Western Australian Institute for Medical Research, Perth, Australia (R.G.)

Address correspondence to Gabriele Bergers, University of California San Francisco, Department of Neurological Surgery, 513 Parnassus Ave., Box 0520, San Francisco, CA 94143-0520, USA (gabriele.bergers{at}ucsf.edu).

Glioblastoma multiforme (GBM) is one the most aggressive brain tumors due to the fast and invasive growth that is partly supported by the presence of extensive neovascularization. The matrix metalloproteinase MMP-2 has been associated with invasive and angiogenic properties in gliomas and is a marker of poor prognosis. Since MMP-2 is expressed in both tumor cells and endothelial cells in GBM, we generated genetically engineered MMP-2 knockout (MMP-2ko) GBM to examine the importance of the spatial expression of MMP-2 in tumor and/or normal host-derived cells. MMP-2–dependent effects appeared to be dose-dependent irrespective of its expression pattern. GBM completely devoid of MMP-2 exhibited markedly increased vascular density associated with vascular endothelial growth factor receptor 2 (VEGFR2) activation and enhanced vascular branching and sprouting. Surprisingly, despite the high vascular density, tumor cells were more prone to apoptosis, which led to prolonged survival of tumor-bearing mice, suggesting that the increased vascularity is not functional. Congruently, tumor vessels were poorly perfused, exhibited lower levels of VEGFR2, and did not undergo proper maturation because pericytes of MMP-2ko tumors were not activated and were less abundant. As a result of impaired and dysfunctional angiogenesis, MMP-2ko GBM became more invasive, predominantly by migrating along blood vessels into the brain parenchyma.

Key Words: angiogenesis • glioblastoma multiforme • invasion • matrix metalloproteinase-2 • survival







  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2008 by Society for Neuro-Oncology